Clinical implications for MSI, MLH1 methylation analysis and IHC in Lynch screening for endometrial cancer patients: An analysis of 940 endometrioid endometrial cancer cases from the GOG 0210 study
C.C. Billingsley , D.E. Cohn , D.G. Mutch , R. Broaddus
Gynecologic Oncology 137 4 -5
2015
Pre-surgical window study of metformin in obesity-driven endometrial cancer
V.N. Sivalingam , R. McVey , S. Kitson , K. Gilmour
Gynecologic Oncology 137 18
3
2015
Clinicopathologic features associated with defective DNA mismatch repair (MMR): A GOG 0210 cohort study of 1041 endometrioid endometrial cancer cases
D.G. Mutch , M.A. Powell , A. Schmidt , R. Broaddus
Gynecologic Oncology 137 20 -21
2015
Increased serum carcinomic antigen 19-9(CA 19-9) in a dermoid cyst
S. Nanayakkara , S. Ali , K. Gilmour
Journal of Obstetrics and Gynaecology 27 ( 1) 96 -97
7
2007
GE-07THE GENOMIC LANDSCAPE OF DIVERSE BRAIN TUMORS REVEALS KNOWN AND NOVEL ONCOGENIC ALTERATIONS FREQUENTLY ASSOCIATED WITH SENSITIVITY TO TARGETED INHIBITORS.
J. Chmielecki , G. Frampton , D. Morosini , S. Ali
Neuro-oncology 16
2014
Expression patterns of the Wnt pathway inhibitors Dickkopf3 (Dkk3) and secreted frizzled-related proteins (SFRP) 1 and 4 in endometrial endometrioid adenocarcinoma: A Gynecologic Oncology Group study
T. Dellinger , R. Eskander , S. Ali , H. Lankes
Gynecologic Oncology 125 ( 1)
1
2012
Expression patterns of the Wnt pathway inhibitor dickKOPF-3 (Dkk3) and secreted frizzled-related proteins (sFRP) 1 and 4 in endometrial endometrioid adenocarcinoma: A gynecologic oncology group study
R. Eskander , S. Ali , H. Lankes , T. Dellinger
Gynecologic Oncology 127 ( 1) S5
1
2012
A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally advanced squamous cell carcinoma of the vulva: A Gynecologic Oncology Group study
D. Moore , S. Ali , M. Barnes , W. Koh
Gynecologic Oncology 120 S2
1
2011
A Gynecologic Oncology Group phase III randomized trial of weekly cisplatin and radiation versus cisplatin and tirapazamine and radiation in stage IB2, IIA, IIIB and IVA cervical carcinoma limited to the pelvis
P. DiSilvestro , S. Ali , C. Peter , N. Spirtos
Gynecologic Oncology 125
9
2012
Radiation {+/-}cisplatin for bulky stage IB cervical carcinoma; Long-term follow-up of a GOG trial
F. B. Stehman , S. Ali , D. G. Gallup , H. Key
Journal of Clinical Oncology 24 5015 -5015
2
2006
MA16.05 MET Kinase Domain Rearrangements (KDRE) in Non-Small Cell Lung Cancer (NSCLC) Identified Through Comprehensive Genomic Profiling (CGP)
A. Schrock , D. Pavlick , M. Rosenzweig , R. Erlich
Journal of Thoracic Oncology 13 ( 10)
1
2018
RET fusions in a small subset of advanced colorectal cancers at risk of being neglected
F. Pietrantonio , F. Di Nicolantonio , A.B. Schrock , J. Lee
Annals of Oncology 29 ( 6) 1394 -1401
74
2018
Broad detection of alterations predicted to confer lack of benefit from EGFR antibodies or sensitivity to targeted therapy in advanced colorectal cancer
S.J. Klempner , A. Rankin , R.L. Erlich , J. Sun
Annals of Oncology 27
39
2016
PURE-02: An open label, multicenter, single-arm, phase 2 study of neoadjuvant pembrolizumab (Pembro), preceding radical nephroureterectomy (RNU), for patients with localized high-risk urothelial carcinoma of the upper urinary tract (UTUC)
A. Necchi , D. Raggi , K. Gust , D. D’Andrea
European Urology Supplements 18 ( 1)
2
2019
OA 12.08 Genomic Analysis of Non-Small Cell Lung Cancer (NSCLC) Cases with Focal and Non-Focal MET Amplification
S. Ou , D. Pavlick , P.J. Stephens , J. Ross
Journal of Thoracic Oncology 12 ( 11) S1778 -S1779
2017
MA 12.03 Kinase Fusions as Recurrent Mechanisms of Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)
S. Ou , S. Klempner , B. Creelan , W.S. Hsieh
Journal of Thoracic Oncology 12 ( 11)
2
2017
Comprehensive Genomic Profiling and Precision Pathology for Clinically Advanced Salivary Gland Myoepithelial Carcinoma
C.V. Ikpeazu , J.A. Elvin , J. Vergilio , J. Suh
International Journal of Radiation Oncology Biology Physics 100 ( 5) 1379 -1380
2018
Prevalence of intestinal parasites among food handlers in Al-Medinah.
S. Inseram Ali , Khursheed Jamal , S.M. Hussain Qadri
Annals of Saudi Medicine 12 ( 1) 63 -66
17
1992
Abstract PD3-10: Higher serum PD-L1 predicts for increased overall survival to lapatinib vs trastuzumab in the phase 3 CCTG MA.31 trial
PR Moku , LE Shepherd , SM Ali , K Leitzel
Cancer Research 79
2019
Abstract A32: MCL1 gene amplification in breast cancer is associated with TNBC status and can respond to a sorafenib/vorinostat regimen
JS Ross , K Wang , A Johnson , J Watson
Molecular Cancer Research 14
2016
Alexa Schrock Garrett M Frampton Doron Lipson Sai-Hong Ignatius Ou Samuel Klempner, MD Zachary R Chalmers James X. Sun Roman Yelensky Sumanta Pal David M. Sabatini Shridar Ganesan Sugganth Daniel Dos Sarbassov Lee Albacker maurizio colecchia Do-Hyung Kim Alberto Briganti Christine M. Lovly, MD, PhD Andrea Gallina